ARCHIVES

Two Studies Demonstrate Molecule Blocking Cell Damage

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992